JP

Jagdishbhai Patel

Active Director Designated Partner DIN 07610322
DIN 07610322 First appointment Sep 2016 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2016
Shareholding value •••• Premium profile

About Jagdishbhai Patel

Data last updated:

Jagdishbhai Patel is a Designated Partner at Nucare Labs Llp (since 2016). The company operates in Pharma. Nucare Labs Llp reported revenue of ₹15.24 Cr (FY 2023).

DIN 07610322
Primary Designation Designated Partner
Industry Pharma
First Appointment 30 Sep 2016
Oldest Company Age 10 yrs
Largest company Nucare Labs Llp · ₹15.24 Cr (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Nucare Labs Llp AAH-5212
Designated Partner30 Sep 20162016₹15.24 Cr (FY 2023)Active

Board colleagues of Jagdishbhai Patel

NameDINCompanyDesignation
Ronak Jagdishbhai Patel07610935Nucare Labs LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Nucare Labs Llp
Premium access

Shareholding and investment profile for Jagdishbhai Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jagdishbhai Patel

Jagdishbhai Patel currently holds 1 directorship: Nucare Labs Llp (Designated Partner, since 30 Sep 2016, revenue ₹15.24 Cr (FY 2023)).

Jagdishbhai Patel was first appointed on 30 Sep 2016 as Designated Partner at Nucare Labs Llp.

The current boards of Jagdishbhai Patel's companies include Ronak Jagdishbhai Patel (Nucare Labs Llp).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available